查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2130851

基於雲端的生物銀行市場分析與預測（至2035年）：按類型、產品、服務、技術、組件、應用、部署方式、最終用戶和解決方案分類

Cloud Based Biobanking Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Deployment, End User, Solutions
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球雲端生物銀行市場預計將從2025年的5.318億美元成長到2035年的7.231億美元，複合年成長率（CAGR）為3.1%。隨著研究機構、製藥公司、醫院和生物技術公司將其檢體管理工作流程遷移到高度擴充性的數位基礎設施，雲端生物銀行市場的需求預計將持續成長。這種趨勢的動力來自與生物樣本相關的基因組學、臨床、蛋白質組學、代謝體學和影像數據量的不斷成長。雲端平台能夠實現集中式庫存管理、遠端資料存取、自動化工作流程協調、安全協作、進階分析以及與實驗室資訊系統的整合。隨著生物樣本庫擴展其跨機構研究網路並需要能夠處理分散式儲存庫的互通系統，需求將進一步成長。人工智慧、機器學習和多體學分析的日益普及也進一步推動了對靈活的雲端生物銀行基礎設施的投資。

這些服務涵蓋生物樣本的整個數位化和營運生命週期，從標準化採集和處理到基於雲端的庫存管理、儲存監控、分發、分析和合規管理。雲端平台整合了樣本元元資料、儲存歷史記錄、檢查室工作流程和分析資料集，從而提升了可追溯性、可存取性、擴充性以及跨地域分散機構的協作能力。檢體儲存正日益將實體儲存設施與基於雲端的資訊管理、自動化監控、備份和災害復原功能結合。數據分析服務支持基因組學、蛋白質組學、影像學和臨床數據的整合。監管合規服務涵蓋知情同意、隱私、可審計性、資料管治和存取控制等面向。這一成長是由不斷成長的檢體量、分散式研究網路以及對互通基礎設施的需求所驅動的。

市場區隔
種類 自動化生物銀行、虛擬生物銀行及其他
產品 軟體、LIMS、生物樣本庫資料管理工具等。
服務 檢體管理、數據分析、諮詢服務及其他服務。
科技 雲端運算、人工智慧/機器學習、區塊鏈、物聯網整合等。
成分 儲存解決方案、資料安全解決方案、網路解決方案等。
目的 研究與開發、臨床試驗、再生醫學及其他
部署方法 公共雲端、私有雲端、混合雲端及其他
最終用戶 製藥公司、學術機構、研究機構、生技公司及其他
解決方案 數據整合解決方案、檢體追蹤解決方案、合規解決方案等。

這些應用主要集中在研究密集的醫學和生命科學領域，這些領域需要安全地存取高品質的生物檢體和相關資料集。疾病研究利用縱向樣本來識別生物標記、疾病機制和群體層級模式，而臨床試驗則需要標準化的樣本管理和快速的資料存取。特別是基因組學，會產生大規模的資料集，因此需要可擴展的雲端運算。另一方面，個人化醫療結合了分子、臨床和表現型訊息，以支持患者分層和標靶治療治療。藥物研發機構利用整合的生物樣本庫資料集進行標靶辨識、生物標記檢驗、轉化研究和化合物開發。隨著多組體學應用的擴展和機構間合作的增加，預計這些應用中的雲端運算採用率將進一步提高。

區域概覽

北美在基於雲端的生物銀行保持著強勁的地位，這得益於其廣泛的生物醫學研究基礎設施、眾多製藥和生物技術公司、先進的定序能力以及完善的臨床研究網路。美國受惠於大規模的人口樣本庫、先進的實驗室資訊系統以及充足的公共和私人研究經費。雲端技術的應用對於基因組學、精準醫療、臨床研究和多組體學工作流程尤其重要，因為這些都需要可擴展的運算資源。美國對生物銀行的需求主要來自對自動化檢體處理、人工智慧分析和數位化樣本庫管理的投資。產業預測，美國生物樣本庫市場規模將在2024年達到171億美元，並將持續成長至2030年。

在歐洲，基於雲端的生物銀行正透過聯邦基礎設施、跨國研究合作、資料互通性計畫和協調一致的公共研究計畫得到加強。 BBMRI-ERIC 提供了一個成熟的區域框架，透過標準化的數位基礎設施連接約 700 個生物樣本庫、超過 2500 個樣本和資料集以及超過 1 億個樣本。其不斷發展的聯邦架構使各機構能夠在保持分散管理的同時，提高樣本的可發現性和隱私保護的資料交換。 2025-2027 年的工作舉措進一步強調生物樣本庫的數位化、安全的雲端環境、互通性和先進的研究存取。支持更多生物樣本庫整合的資助計畫有望擴大基於雲端的合作，並加強歐洲在數位化互聯生物銀行領域的作用。

主要趨勢和促進因素

從生物樣本庫到智慧雲生態系：

生物銀行正從孤立的儲存庫管理模式轉向互聯互通、基於雲端的數據生態系統，該系統將生物檢體庫存資訊與臨床、基因組、影像、蛋白質組學和表現型數據相結合。聯合架構的重要性日益凸顯，因為它們既能實現安全搜尋和受控資料交換，又能允許各機構保持在地管理控制。 BBMRI-ERIC正透過可互通的基礎設施和安全的雲端環境來推動此模式的發展，而英國生物樣本庫則透過其研究分析平台展示了大規模雲端分析能力。這種轉變正在推動對支援API的平台、標準化元資料、自動化工作流程、人工智慧驅動的分析以及安全的多機構協作研究環境的需求不斷成長。

數據的爆炸性成長正在推動雲端生物銀行的普及：

基因組和多體學資料集的規模和複雜性日益成長，加速了對可擴展的雲端生物銀行基礎設施的需求。現代生物樣本庫擴大將生物檢體與定序、蛋白質組學、代謝體學、影像學、臨床和縱向資料集相結合，對研究人員的靈活計算、儲存、分析和存取管理提出了更高的要求。英國生物樣本庫的雲端基礎設施支援存取約50萬名參與者的全基因測序數據，使研究人員無需維護同等的本地運算能力即可分析大規模資料集。這種基礎設施降低了技術門檻，促進了合作，並支持精準醫療、生物標記發現、臨床研究和藥物研發等領域日益成長的數據密集型工作流程。

目錄

第1章執行摘要

第2章 市場概覽

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：基於細分市場的分析

  • 市場規模及預測：依類型
    • 自動化生物銀行
    • 虛擬生物銀行
    • 其他
  • 市場規模及預測：依產品分類
    • 軟體
    • LIMS（實驗室資訊管理系統）
    • 生物樣本庫資料管理工具
    • 其他
  • 市場規模及預測：依服務分類
    • 檢體管理
    • 數據分析
    • 諮詢服務
    • 其他
  • 市場規模及預測：依技術分類
    • 雲端運算
    • 人工智慧（AI）和機器學習（ML）
    • 區塊鏈
    • 物聯網整合
    • 其他
  • 市場規模及預測：依組件分類
    • 儲存解決方案
    • 資料安全解決方案
    • 網路解決方案
    • 其他
  • 市場規模及預測：依應用領域分類
    • 研究與開發
    • 臨床試驗
    • 再生醫學
    • 其他
  • 市場規模及預測：依部署方式分類
    • 公共雲端
    • 私有雲端
    • 混合雲端
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 製藥公司
    • 學術機構
    • 研究機構
    • 生技公司
    • 其他
  • 市場規模及預測：按解決方案分類
    • 數據整合解決方案
    • 檢體追蹤解決方案
    • 合規解決方案
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 其他亞太國家
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲國家

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 大公司的策略

第8章：公司簡介

  • Thermo Fisher Scientific
  • Qiagen
  • Brooks Life Sciences
  • Biobank
  • LabVantage Solutions
  • CloudLIMS
  • BC Platforms
  • BioData
  • Repositive
  • Genohm
  • RURO
  • AgileBio
  • LabWare
  • Bio-ITech
  • Arxspan
  • LabArchives
  • Core Informatics
  • Titian Software
  • Benchling
  • Sapio Sciences

第9章：關於Global Insight Services

簡介目錄
Product Code: GIS10908

The global Cloud Based Biobanking Market is projected to grow from $531.8 Million in 2025 to $723.1 Million by 2035, at a compound annual growth rate (CAGR) of 3.1%. The cloud-based biobanking market is experiencing sustained demand as research organizations, pharmaceutical companies, hospitals, and biotechnology firms migrate specimen-management workflows toward scalable digital infrastructure. Adoption is being supported by increasing volumes of genomic, clinical, proteomic, metabolomic, and imaging data associated with biological samples. Cloud platforms enable centralized inventory management, remote data access, automated workflow coordination, secure collaboration, advanced analytics, and integration with laboratory information systems. Demand is also strengthening as biobanks expand cross-institutional research networks and require interoperable systems capable of handling distributed repositories. Increasing use of artificial intelligence, machine learning, and multi-omics analysis is further encouraging investment in flexible cloud-based biobanking infrastructure.

Services encompass the complete digital and operational lifecycle of biospecimens, from standardized collection and processing to cloud-enabled inventory, storage monitoring, distribution, analytics, and compliance management. Cloud platforms integrate sample metadata, chain-of-custody records, laboratory workflows, and analytical datasets, improving traceability, accessibility, scalability, and collaboration across geographically distributed facilities. Sample storage increasingly combines physical repositories with cloud-based information management, automated monitoring, backup, and disaster-recovery capabilities. Data analysis services support genomic, proteomic, imaging, and clinical-data integration. Regulatory compliance services address consent, privacy, auditability, data governance, and controlled access. Growth is supported by expanding specimen volumes, distributed research networks, and demand for interoperable infrastructure.

Market Segmentation
TypeAutomated Biobanking, Virtual Biobanking, Others
ProductSoftware, LIMS (Laboratory Information Management Systems), Biobank Data Management Tools, Others
ServicesSample Management, Data Analysis, Consulting Services, Others
TechnologyCloud Computing, AI and Machine Learning, Blockchain, IoT Integration, Others
ComponentStorage Solutions, Data Security Solutions, Networking Solutions, Others
ApplicationResearch and Development, Clinical Trials, Regenerative Medicine, Others
DeploymentPublic Cloud, Private Cloud, Hybrid Cloud, Others
End UserPharmaceutical Companies, Academic Institutions, Research Organizations, Biotechnology Companies, Others
SolutionsData Integration Solutions, Sample Tracking Solutions, Compliance Solutions, Others

Applications are concentrated across research-intensive healthcare and life-science activities requiring secure access to high-quality biospecimens and associated datasets. Disease research uses longitudinal samples to identify biomarkers, disease mechanisms, and population-level patterns, while clinical trials depend on standardized specimen management and rapid data accessibility. Genomics generates particularly large datasets requiring scalable cloud computing, while personalized medicine combines molecular, clinical, and phenotypic information to support patient stratification and targeted therapies. Drug discovery organizations use integrated biobank datasets for target identification, biomarker validation, translational research, and compound development. Increasing multi-omics adoption and cross-institutional collaboration should strengthen cloud deployment across these applications.

Geographical Overview

North America maintains a strong position in cloud-based biobanking because of its extensive biomedical research infrastructure, concentration of pharmaceutical and biotechnology companies, advanced sequencing capabilities, and established clinical research networks. The U.S. benefits from large population-based repositories, sophisticated laboratory information systems, and substantial public and private research funding. Cloud adoption is particularly relevant to genomics, precision medicine, clinical research, and multi-omics workflows requiring scalable computational resources. U.S. biobanking demand is supported by investments in automated sample processing, AI-enabled analytics, and digital repository management. Commercial estimates place the U.S. biobanks market at USD 17.1 billion in 2024, with continued expansion through 2030.

Europe is strengthening cloud-based biobanking through federated infrastructure, cross-border research collaboration, data interoperability initiatives, and coordinated public research programs. BBMRI-ERIC provides an established regional framework connecting nearly 700 biobanks, more than 2,500 sample and data collections, and over 100 million samples through standardized digital infrastructure. Its evolving federated architecture enables institutions to retain decentralized control while improving sample discoverability and privacy-protected data exchange. The 20252027 work programme places additional emphasis on biobank datafication, secure cloud environments, interoperability, and advanced research access. Funding initiatives supporting integration of additional biobanks are expected to expand cloud-enabled collaboration and strengthen Europe's role in digitally connected biobanking.

Key Trends and Drivers

From Biobanks to Intelligent Cloud Ecosystems:

Biobanking is shifting from isolated repository management toward interconnected, cloud-enabled data ecosystems that combine biospecimen inventories with clinical, genomic, imaging, proteomic, and phenotypic information. Federated architectures are gaining importance because they allow institutions to retain local control while enabling secure discovery and controlled data exchange. BBMRI-ERIC is advancing this model through interoperable infrastructure and secure cloud environments, while UK Biobank demonstrates large-scale cloud analysis through its Research Analysis Platform. This transition is increasing demand for API-enabled platforms, standardized metadata, automated workflows, AI-supported analytics, and secure multi-institutional research environments.

The Data Explosion Powering Cloud Biobanking Adoption:

The expanding volume and complexity of genomic and multi-omics datasets is accelerating demand for scalable cloud-based biobanking infrastructure. Modern repositories increasingly combine biospecimens with sequencing, proteomics, metabolomics, imaging, clinical, and longitudinal datasets, creating substantial requirements for flexible computing, storage, analytics, and controlled researcher access. UK Biobank's cloud-based infrastructure supports access to whole-genome sequencing data from approximately 500,000 participants and enables researchers to analyze large datasets without maintaining equivalent local computing capacity. Such infrastructure reduces technology barriers, facilitates collaboration, and supports increasingly data-intensive precision medicine, biomarker discovery, clinical research, and drug-development workflows.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by Deployment
  • 2.8 Key Market Highlights by End User
  • 2.9 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Automated Biobanking
    • 4.1.2 Virtual Biobanking
    • 4.1.3 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Software
    • 4.2.2 LIMS (Laboratory Information Management Systems)
    • 4.2.3 Biobank Data Management Tools
    • 4.2.4 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Sample Management
    • 4.3.2 Data Analysis
    • 4.3.3 Consulting Services
    • 4.3.4 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Cloud Computing
    • 4.4.2 AI and Machine Learning
    • 4.4.3 Blockchain
    • 4.4.4 IoT Integration
    • 4.4.5 Others
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Storage Solutions
    • 4.5.2 Data Security Solutions
    • 4.5.3 Networking Solutions
    • 4.5.4 Others
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Research and Development
    • 4.6.2 Clinical Trials
    • 4.6.3 Regenerative Medicine
    • 4.6.4 Others
  • 4.7 Market Size & Forecast by Deployment (2020-2035)
    • 4.7.1 Public Cloud
    • 4.7.2 Private Cloud
    • 4.7.3 Hybrid Cloud
    • 4.7.4 Others
  • 4.8 Market Size & Forecast by End User (2020-2035)
    • 4.8.1 Pharmaceutical Companies
    • 4.8.2 Academic Institutions
    • 4.8.3 Research Organizations
    • 4.8.4 Biotechnology Companies
    • 4.8.5 Others
  • 4.9 Market Size & Forecast by Solutions (2020-2035)
    • 4.9.1 Data Integration Solutions
    • 4.9.2 Sample Tracking Solutions
    • 4.9.3 Compliance Solutions
    • 4.9.4 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 Deployment
      • 5.2.1.8 End User
      • 5.2.1.9 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 Deployment
      • 5.2.2.8 End User
      • 5.2.2.9 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 Deployment
      • 5.2.3.8 End User
      • 5.2.3.9 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 Deployment
      • 5.3.1.8 End User
      • 5.3.1.9 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 Deployment
      • 5.3.2.8 End User
      • 5.3.2.9 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 Deployment
      • 5.3.3.8 End User
      • 5.3.3.9 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 Deployment
      • 5.4.1.8 End User
      • 5.4.1.9 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 Deployment
      • 5.4.2.8 End User
      • 5.4.2.9 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 Deployment
      • 5.4.3.8 End User
      • 5.4.3.9 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 Deployment
      • 5.4.4.8 End User
      • 5.4.4.9 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 Deployment
      • 5.4.5.8 End User
      • 5.4.5.9 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 Deployment
      • 5.4.6.8 End User
      • 5.4.6.9 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 Deployment
      • 5.4.7.8 End User
      • 5.4.7.9 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 Deployment
      • 5.5.1.8 End User
      • 5.5.1.9 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 Deployment
      • 5.5.2.8 End User
      • 5.5.2.9 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 Deployment
      • 5.5.3.8 End User
      • 5.5.3.9 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 Deployment
      • 5.5.4.8 End User
      • 5.5.4.9 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 Deployment
      • 5.5.5.8 End User
      • 5.5.5.9 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 Deployment
      • 5.5.6.8 End User
      • 5.5.6.9 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 Deployment
      • 5.6.1.8 End User
      • 5.6.1.9 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 Deployment
      • 5.6.2.8 End User
      • 5.6.2.9 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 Deployment
      • 5.6.3.8 End User
      • 5.6.3.9 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 Deployment
      • 5.6.4.8 End User
      • 5.6.4.9 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 Deployment
      • 5.6.5.8 End User
      • 5.6.5.9 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Thermo Fisher Scientific
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Qiagen
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Brooks Life Sciences
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Biobank
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 LabVantage Solutions
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 CloudLIMS
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 BC Platforms
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 BioData
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Repositive
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Genohm
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 RURO
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 AgileBio
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 LabWare
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Bio-ITech
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Arxspan
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 LabArchives
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Core Informatics
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Titian Software
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Benchling
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Sapio Sciences
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us